Multiple Sclerosis Society of Canada

Translational and Commercial Research Advisory Committee


Ms. Kathryn Smith
Business consultant to for-profit and not-for-profit healthcare companies and foundations


Dr. Samuel David
Basic Scientist, McGill University
Area of expertise: cellular changes and molecular mechanisms that influence inflammation following nerve tissue damage

Dr. Mark Moore
Co-Founder and Chief Executive Officer, Glialogix
Area of expertise: drug discovery and biotechnology start-ups

Dr. John Richert
Principal, Richert Partners
Area of expertise: research and clinical programs in non-profit sector and pharmaceutical development

Ms. Jenny Lee Gauthier
MS Society volunteer and middle school teacher,
Campbellton, NB
Lay member